Moderna, Pfizer and COVID-19

Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
 · 3dThe Pharma Letter
US Patent Board invalidates Moderna vaccine IP
Pfizer and BioNTech violated COVID-19 vaccine patent held by Moderna, German court rules
Zacks Investment Research on MSN3d
Here's Why Moderna Stock Soared 16% on Wednesday
Shares of Moderna MRNA rose nearly 16% yesterday after a couple of SEC filings showed that two board members bought shares on the open market. It also secured a legal victory in a patent dispute against Pfizer PFE and BioNTech BNTX.
Moderna: Patent Litigation Win Masks Underperformance, Unlikely To Pay Out
Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term momentum without new products.
Yahoo Finance4d
Why Moderna (MRNA) Stock Is Rallying Today
MRNA's Court Victory A German court ruled that BioNTech (BNTX) and Pfizer (PFE) have to pay Moderna damages because they infringed on Moderna's mRNA patents. The court ordered BNTX and PFE to ...
CDC plans study into potential vaccines, autism connections, Reuters reports
The U.S. CDC plans to embark on a large study into potential connections between vaccines and autism, despite extensive scientific research